Cargando…
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer’s disease
Although the amyloid β-protein (Aβ) is believed to play an initiating role in Alzheimer’s disease (AD), the molecular characteristics of the key pathogenic Aβ forms are not well understood. As a result, it has proved difficult to identify optimal agents that target disease-relevant forms of Aβ. Here...
Autores principales: | Jin, Ming, O’Nuallain, Brian, Hong, Wei, Boyd, Justin, Lagomarsino, Valentina N., O’Malley, Tiernan T., Liu, Wen, Vanderburg, Charles R., Frosch, Matthew P., Young-Pearse, Tracy, Selkoe, Dennis J., Walsh, Dominic M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041266/ https://www.ncbi.nlm.nih.gov/pubmed/29992960 http://dx.doi.org/10.1038/s41467-018-05068-w |
Ejemplares similares
-
IgG Conformer's Binding to Amyloidogenic Aggregates
por: Phay, Monichan, et al.
Publicado: (2015) -
Learnings about Aβ from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer’s disease immunotherapeutics
por: Wang, Zemin, et al.
Publicado: (2023) -
A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid
por: Yang, Ting, et al.
Publicado: (2015) -
Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity
por: Hu, Neng-Wei, et al.
Publicado: (2018) -
Is Europe prepared to go digital? making the case for developing digital capacity: An exploratory analysis of Eurostat survey data
por: van Kessel, Robin, et al.
Publicado: (2022)